1. Home
  2. PIPR vs KRYS Comparison

PIPR vs KRYS Comparison

Compare PIPR & KRYS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Piper Sandler Companies

PIPR

Piper Sandler Companies

HOLD

Current Price

$294.62

Market Cap

5.8B

Sector

Finance

ML Signal

HOLD

Logo Krystal Biotech Inc.

KRYS

Krystal Biotech Inc.

HOLD

Current Price

$257.49

Market Cap

7.8B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
PIPR
KRYS
Founded
1895
2015
Country
United States
United States
Employees
N/A
N/A
Industry
Investment Bankers/Brokers/Service
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
5.8B
7.8B
IPO Year
2003
2017

Fundamental Metrics

Financial Performance
Metric
PIPR
KRYS
Price
$294.62
$257.49
Analyst Decision
Buy
Strong Buy
Analyst Count
3
10
Target Price
$365.50
$297.60
AVG Volume (30 Days)
176.9K
219.9K
Earning Date
05-01-2026
05-05-2026
Dividend Yield
2.64%
N/A
EPS Growth
54.49
128.00
EPS
15.82
6.84
Revenue
$1,904,217,000.00
$389,130,000.00
Revenue This Year
$13.09
$40.88
Revenue Next Year
$14.76
$35.16
P/E Ratio
$18.70
$36.75
Revenue Growth
24.33
33.94
52 Week Low
$202.91
$123.03
52 Week High
$380.26
$298.30

Technical Indicators

Market Signals
Indicator
PIPR
KRYS
Relative Strength Index (RSI) 42.59 46.36
Support Level $276.37 $251.93
Resistance Level $341.25 $293.60
Average True Range (ATR) 9.58 9.21
MACD 1.87 -0.71
Stochastic Oscillator 59.12 45.69

Price Performance

Historical Comparison
PIPR
KRYS

About PIPR Piper Sandler Companies

Piper Sandler Cos is an investment bank and institutional securities firm, serving the needs of corporations, private equity groups, public entities, non-profit entities and institutional investors in the United States (U.S.) and internationally. The company provides a broad set of products and services, including financial advisory services; equity and debt capital markets products; public finance services; institutional brokerage services; fundamental equity and macro research services; fixed income services; and alternative asset management strategies. It generates maximum revenue from Advisory services followed by Equity financing.

About KRYS Krystal Biotech Inc.

Krystal Biotech Inc is engaged in the healthcare sector in the United States. It is focused on the development of easy-to-use, redosable gene therapies to improve the lives of patients living with debilitating diseases. The company used its proprietary gene therapy platform, STAR-D to develop treatments for rare or orphan dermatological indications caused by the absence of or a mutation in a single gene. It plans to leverage its platform to expand its pipeline to include other dermatological indications in the future. The company has one operating segment, which is the business of developing and commercializing pharmaceutical products.

Share on Social Networks: